Ultrasound market-growth expected in emerging markets
This article was originally published in Clinica
The ultrasound market in the emerging economies of the Far East, Asia and Latin America may be worth $778 million by the year 2000 if predictions in a report from MarketLine International are met. The value of the ultrasound market in developing countries increased by 6.6% to $603 million between 1992 and 1996.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.